JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ulus, I. H.
Right arrow Articles by Wurtman, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ulus, I. H.
Right arrow Articles by Wurtman, R. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

Vol. 281, Issue 1, 149-154, 1997

Metabotropic Glutamate Receptor Agonists Increase Release of Soluble Amyloid Precursor Protein Derivatives from Rat Brain Cortical and Hippocampal Slices1

Ismail H. Ulus2 and Richard J. Wurtman

Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts

The proteolytic processing of the beta -amyloid precursor protein (APP) is regulated by neurotransmitters. Stimulation of metabotropic glutamate receptors (mGluRs) has been shown to increase the release of soluble amyloid precursor protein derivatives (APPs) from cultured cells. We examined the effects of mGluR agonists on APP processing in cortical and hippocampal slices from rat brain. Incubation of the slices in the presence of L-glutamic acid (500 µM), trans-(1S,3R)-1-amino-1,3-cyclopentane dicarboxylic acid (1-100 µM) or quisqualic acid (1-100 µM) increased APP release into the medium, relative to the amount of APPs released during incubation in normal Krebs-Ringer buffer under basal conditions. N-Methyl-D-aspartate (1-320 µM), (±)-alpha -amino-3-hydroxy-5-methylisoxazole-4-propionic acid (1-100 µM) or kainic acid (5-500 µM) did not alter APP release. The increases in APP release induced by L-glutamic acid (500 µM), trans-(1S,3R)-1-amino-1,3-cyclopentane dicarboxylic acid (10 µM) or quisqualic acid (10 µM) were blocked by 100 µM (±)-alpha -methyl-4-carboxyphenylglycine, a selective antagonist of mGluRs. Incubation of the slices in the presence of 1 µM phorbol-12-myrisate-13-acetate, an activator of protein kinase C (PKC), also increased APP release, and an inhibitor of PKC, GF-109203X (1 µM), blocked this response as well as the release evoked by mGluR agonists. These data show that activation of mGluR increases APP release from brain slices via PKC-dependent mechanisms.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Neurosci.Home page
R. K. K. Lee, S. Knapp, and R. J. Wurtman
Prostaglandin E2 Stimulates Amyloid Precursor Protein Gene Expression: Inhibition by Immunosuppressants
J. Neurosci., February 1, 1999; 19(3): 940 - 947.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Jolly-Tornetta, Z.-y. Gao, V. M.-Y. Lee, and B. A. Wolf
Regulation of Amyloid Precursor Protein Secretion by Glutamate Receptors in Human Ntera 2 Neurons (NT2N)
J. Biol. Chem., May 29, 1998; 273(22): 14015 - 14021.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.